Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IKK inhibition increases bortezomib effectiveness in ovarian cancer
Bipradeb Singha, Himavanth R. Gatla, Sai Phyo, et al.
Oncotarget (2015) Vol. 6, Iss. 28, pp. 26347-26358
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Yuan Cheng, Xuelei Ma, Yuquan Wei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1871, Iss. 2, pp. 289-312
Open Access | Times Cited: 266
Positioning of proteasome inhibitors in therapy of solid malignancies
Margot S. F. Roeten, Jacqueline Cloos, Gerrit Jansen
Cancer Chemotherapy and Pharmacology (2017) Vol. 81, Iss. 2, pp. 227-243
Open Access | Times Cited: 129
NF-κB Signaling in Ovarian Cancer
Brittney S. Harrington, Christina M. Annunziata
Cancers (2019) Vol. 11, Iss. 8, pp. 1182-1182
Open Access | Times Cited: 101
Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer
Marcela Moisés Maluf Sanguinete, Paula Honório De Oliveira, Agrimaldo Martins-Filho, et al.
Immunological Investigations (2017) Vol. 46, Iss. 7, pp. 677-688
Closed Access | Times Cited: 99
Tumor–Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure
Elke Pogge von Strandmann, Silke Reinartz, Uwe Wager, et al.
Trends in cancer (2017) Vol. 3, Iss. 2, pp. 137-148
Open Access | Times Cited: 97
Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
Himavanth R. Gatla, Nethaji Muniraj, Prashanth Thevkar, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1110-1110
Open Access | Times Cited: 83
IL‐8 promotes cell migration through regulating EMT by activating the Wnt/β‐catenin pathway in ovarian cancer
Jirui Wen, Zhiwei Zhao, Liwei Huang, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 2, pp. 1588-1598
Open Access | Times Cited: 71
Bortezomib advanced mechanisms of action in multiple myeloma, solid and liquid tumors along with its novel therapeutic applications.
Mohammad Alwahsh, Joviana Farhat, Shahd Talhouni, et al.
PubMed (2023) Vol. 22, pp. 146-168
Closed Access | Times Cited: 19
Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin
Spiros Vlahopoulos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8621-8621
Open Access | Times Cited: 7
Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells
Himavanth R. Gatla, Yue Zou, Mohammad M. Uddin, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 12, pp. 5043-5054
Open Access | Times Cited: 42
CXCL8 Promotes Endothelial-to-Mesenchymal Transition of Endothelial Cells and Protects Cells from Erastin-Induced Ferroptosis via CXCR2-Mediated Activation of the NF-κB Signaling Pathway
Haizhou Ji, Li Chen, Mi Ren, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1210-1210
Open Access | Times Cited: 10
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells—Power of nutraceuticals
James A. McCubrey, Stephen L. Abrams, Kvin Lertpiriyapong, et al.
Advances in Biological Regulation (2017) Vol. 67, pp. 190-211
Closed Access | Times Cited: 28
IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance
Suprataptha U. Reddy, Fatema Zohra Sadia, Aleš Vančura, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2676-2676
Open Access | Times Cited: 2
Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 2
Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells
Himavanth R. Gatla, Yue Zou, Mohammad M. Uddin, et al.
Oncotarget (2017) Vol. 8, Iss. 41, pp. 70798-70810
Open Access | Times Cited: 20
IL-6 and IL-8 are involved in JMJD2A-regulated malignancy of ovarian cancer cells
Haiyu Zhang, Zichao Wang, Fengxia Wang, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 684, pp. 108334-108334
Closed Access | Times Cited: 18
CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
Xinxin Huang, Juncheng Hao, Yan Qin Tan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2642-2642
Open Access | Times Cited: 11
Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphoma
Xinhua Xiao, Hui‐Liang Li, Hui‐Zi Jin, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 9, pp. e3050-e3050
Open Access | Times Cited: 17
Inflammatory related gene IKKα, IKKβ, IKKγ cooperates to determine liver cancer stem cells progression by altering telomere via heterochromatin protein 1-HOTAIR axis
Jiahui An, Mengying Wu, Xiaoru Xin, et al.
Oncotarget (2016) Vol. 7, Iss. 31, pp. 50131-50149
Open Access | Times Cited: 15
Cacalol Acetate, a Sesquiterpene from Psacalium decompositum, Exerts an Anti-inflammatory Effect through LPS/NF-KB Signaling in Raw 264.7 Macrophages
B. Mora-Ramiro, Manuel Jiménez‐Estrada, Alejandro Zentella‐Dehesa, et al.
Journal of Natural Products (2020) Vol. 83, Iss. 8, pp. 2447-2455
Closed Access | Times Cited: 15
Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy
Mohammad M. Uddin, Yue Zou, Tamanna Sharma, et al.
PLoS ONE (2018) Vol. 13, Iss. 8, pp. e0201858-e0201858
Open Access | Times Cited: 14
Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and Inflammation
Nefertiti El-Nikhely, Annika Karger, Poonam Sarode, et al.
Cancer Research (2020) Vol. 80, Iss. 19, pp. 4199-4211
Open Access | Times Cited: 12
IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target
Tatiana Carneiro-Lobo, Luiza Coimbra Scalabrini, Leila da Silva Magalhães, et al.
Lung Cancer (2019) Vol. 130, pp. 169-178
Open Access | Times Cited: 9
Fluid shear stress-induced IL-8/CXCR signaling in human ovarian cancer cells
Lei Sun, Jirui Wen, Ling Wang, et al.
Translational Cancer Research (2019) Vol. 8, Iss. 4, pp. 1591-1601
Open Access | Times Cited: 7
HDAC/IKK inhibition therapies in solid tumors
Ivana Vancurova, Himavanth R. Gatla, Aleš Vančura
Oncotarget (2017) Vol. 8, Iss. 21, pp. 34030-34031
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top